Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
To-go cocktails in North Carolina: How does it work?
Recommended
What to know about Shearon Harris Nuclear Plant, emergency plans
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Eli Lilly and Co
Recent news which mentions Eli Lilly and Co
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Jim Cramer supports megacaps for the long term, even as Wall Street continues to sell
July 18, 2024
Tags
Amazon/com Inc
Meta Platforms Inc
Business News
From
CNBC.com News
CNBC Daily Open: Rising geopolitical risk
July 18, 2024
Tags
Obesity
Eli Lilly and Co
Daily Open
From
CNBC.com News
CNBC Daily Open: Rising geopolitical risk
July 17, 2024
Tags
Air travel
Artificial intelligence
Meta Platforms Inc
From
CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
July 17, 2024
Tags
Business
Pharmaceuticals
Zealand Pharma A/S
From
CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
July 16, 2024
Tags
Biotech and Pharmaceuticals
Pfizer Inc
UnitedHealth Group Inc
From
CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
July 11, 2024
Tags
Eli Lilly and Co
Health & Science
Novo Nordisk A/S
From
CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
July 11, 2024
Tags
Health & Science
Pharmaceuticals
US: News
From
CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
July 10, 2024
Tags
U/S/ Markets
Novo Nordisk A/S
Investing
From
CNBC.com News
Jim Cramer reviews 8 companies that could top $1 trillion in market cap
July 10, 2024
Tags
Berkshire Hathaway Inc
Stock markets
Apple Inc
From
CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
July 10, 2024
Tags
Social issues
UnitedHealth Group Inc
US: News
From
CNBC.com News
Companies besides tech can reach megacap status, Jim Cramer says
July 08, 2024
Tags
Meta Platforms Inc
Amazon/com Inc
Business News
From
CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
July 06, 2024
Tags
Weight management
U/S/ Markets
Stock markets
From
CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
Tags
Technology
Healthy Returns
Health care industry
From
CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 03, 2024
Tags
Market Outlook
Asia Markets
Nasdaq Inc
From
CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 02, 2024
Tags
Pharmaceuticals
Nasdaq Inc
Asia Markets
From
CNBC.com News
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
July 02, 2024
Tags
Eli Lilly and Co
US: News
Pharmaceuticals
From
CNBC.com News
Watch now: ETF Edge on reshoring trends, weight loss drugs and more
July 01, 2024
Tags
Eaton Corporation PLC
Alnylam Pharmaceuticals Inc
Exchange/traded funds
From
CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags
Gilead Sciences Inc
Viking Therapeutics Inc
Health & Science
From
CNBC.com News
Jim Cramer's top picks for pet-centric stocks
June 25, 2024
Tags
U/S/ Markets
Eli Lilly and Co
Investing
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
June 25, 2024
Tags
Biotechnology
Biotech and Pharmaceuticals
Europe: Top News And Analysis
From
CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
June 24, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Novo Nordisk A/S
From
CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
June 21, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Business News
From
CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
June 21, 2024
Tags
Zealand Pharma A/S
Europe News
Markets
From
CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags
Labor economy
Biotech and Pharmaceuticals
Social issues
From
CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
June 17, 2024
Tags
Companies
Business
Health care industry
From
CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
Tags
Investing
Eli Lilly and Co
U/S/ Markets
From
CNBC.com News
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
June 10, 2024
Tags
Health & Science
Pharmaceuticals
Business
From
CNBC.com News
Jim Cramer's week ahead: Fed meeting and CPI report
June 07, 2024
Tickers
RH
Tags
Adobe Inc/
Business
Investment Strategy
From
CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
Tags
Biotech and Pharmaceuticals
Pfizer Inc
Science
From
CNBC.com News
Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
June 06, 2024
Tags
Breaking News: Technology
Morgan Stanley
Eli Lilly and Co
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.